Cyclerion Therapeutics,Inc. Stock News
$2.61
19.69%
today
Nasdaq,
Sep 25, 07:46 pm CET
Cyclerion Therapeutics,Inc. Stock News
Neutral
Seeking Alpha
●
one day ago
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call Company Participants Regina Graul - CEO, President & Director Presentation Regina Graul CEO, President & Director Good morning, everyone. Yesterday, we announced Cyclerion's transformational relaunch as a neuropsychiatric company, supported by an MIT licensing agreement that secures foundational intellectual property.
Neutral
GlobeNewsWire
●
2 days ago
Cyclerion has entered into a licensing agreement with MIT, securing the intellectual property that will serve as the cornerstone of its strategic relaunch.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
